The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Voriconazole Market Research Report 2024
Synopsis
The global Voriconazole market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Voriconazole is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Voriconazole is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Voriconazole include Pfizer, Teva, GeneTech Pharm, Novartis, Mylan, Squibb, Sandoz, Daiichi Sankyo and GSK, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Voriconazole, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Voriconazole.
Report Scope
The Voriconazole market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Voriconazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Voriconazole manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Teva
GeneTech Pharm
Novartis
Mylan
Squibb
Sandoz
Daiichi Sankyo
GSK
Cilag AG
Macherey-Nagel GmbH
Abbott
Takeda
Sichuan Beauty Sport Huakang Pharmaceutical
Jincheng HEALTH Pharmaceutical
Ebang Pharmaceutical
Aditya Pharma
Taj Pharmaceuticals
Segment by Type
Injection Voriconazole
Voriconazole Freeze-dried Powder
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Voriconazole manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Voriconazole in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Voriconazole market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Voriconazole is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Voriconazole is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Voriconazole include Pfizer, Teva, GeneTech Pharm, Novartis, Mylan, Squibb, Sandoz, Daiichi Sankyo and GSK, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Voriconazole, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Voriconazole.
Report Scope
The Voriconazole market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Voriconazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Voriconazole manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Teva
GeneTech Pharm
Novartis
Mylan
Squibb
Sandoz
Daiichi Sankyo
GSK
Cilag AG
Macherey-Nagel GmbH
Abbott
Takeda
Sichuan Beauty Sport Huakang Pharmaceutical
Jincheng HEALTH Pharmaceutical
Ebang Pharmaceutical
Aditya Pharma
Taj Pharmaceuticals
Segment by Type
Injection Voriconazole
Voriconazole Freeze-dried Powder
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Voriconazole manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Voriconazole in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Voriconazole Market Overview
1.1 Product Overview and Scope of Voriconazole
1.2 Voriconazole Segment by Type
1.2.1 Global Voriconazole Market Value Comparison by Type (2024-2030)
1.2.2 Injection Voriconazole
1.2.3 Voriconazole Freeze-dried Powder
1.3 Voriconazole Segment by Application
1.3.1 Global Voriconazole Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Voriconazole Market Size Estimates and Forecasts
1.4.1 Global Voriconazole Revenue 2019-2030
1.4.2 Global Voriconazole Sales 2019-2030
1.4.3 Global Voriconazole Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Voriconazole Market Competition by Manufacturers
2.1 Global Voriconazole Sales Market Share by Manufacturers (2019-2024)
2.2 Global Voriconazole Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Voriconazole Average Price by Manufacturers (2019-2024)
2.4 Global Voriconazole Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Voriconazole, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Voriconazole, Product Type & Application
2.7 Voriconazole Market Competitive Situation and Trends
2.7.1 Voriconazole Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Voriconazole Players Market Share by Revenue
2.7.3 Global Voriconazole Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Voriconazole Retrospective Market Scenario by Region
3.1 Global Voriconazole Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Voriconazole Global Voriconazole Sales by Region: 2019-2030
3.2.1 Global Voriconazole Sales by Region: 2019-2024
3.2.2 Global Voriconazole Sales by Region: 2025-2030
3.3 Global Voriconazole Global Voriconazole Revenue by Region: 2019-2030
3.3.1 Global Voriconazole Revenue by Region: 2019-2024
3.3.2 Global Voriconazole Revenue by Region: 2025-2030
3.4 North America Voriconazole Market Facts & Figures by Country
3.4.1 North America Voriconazole Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Voriconazole Sales by Country (2019-2030)
3.4.3 North America Voriconazole Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Voriconazole Market Facts & Figures by Country
3.5.1 Europe Voriconazole Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Voriconazole Sales by Country (2019-2030)
3.5.3 Europe Voriconazole Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Voriconazole Market Facts & Figures by Country
3.6.1 Asia Pacific Voriconazole Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Voriconazole Sales by Country (2019-2030)
3.6.3 Asia Pacific Voriconazole Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Voriconazole Market Facts & Figures by Country
3.7.1 Latin America Voriconazole Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Voriconazole Sales by Country (2019-2030)
3.7.3 Latin America Voriconazole Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Voriconazole Market Facts & Figures by Country
3.8.1 Middle East and Africa Voriconazole Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Voriconazole Sales by Country (2019-2030)
3.8.3 Middle East and Africa Voriconazole Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Voriconazole Sales by Type (2019-2030)
4.1.1 Global Voriconazole Sales by Type (2019-2024)
4.1.2 Global Voriconazole Sales by Type (2025-2030)
4.1.3 Global Voriconazole Sales Market Share by Type (2019-2030)
4.2 Global Voriconazole Revenue by Type (2019-2030)
4.2.1 Global Voriconazole Revenue by Type (2019-2024)
4.2.2 Global Voriconazole Revenue by Type (2025-2030)
4.2.3 Global Voriconazole Revenue Market Share by Type (2019-2030)
4.3 Global Voriconazole Price by Type (2019-2030)
5 Segment by Application
5.1 Global Voriconazole Sales by Application (2019-2030)
5.1.1 Global Voriconazole Sales by Application (2019-2024)
5.1.2 Global Voriconazole Sales by Application (2025-2030)
5.1.3 Global Voriconazole Sales Market Share by Application (2019-2030)
5.2 Global Voriconazole Revenue by Application (2019-2030)
5.2.1 Global Voriconazole Revenue by Application (2019-2024)
5.2.2 Global Voriconazole Revenue by Application (2025-2030)
5.2.3 Global Voriconazole Revenue Market Share by Application (2019-2030)
5.3 Global Voriconazole Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Voriconazole Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Voriconazole Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Teva
6.2.1 Teva Corporation Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Voriconazole Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Teva Voriconazole Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 GeneTech Pharm
6.3.1 GeneTech Pharm Corporation Information
6.3.2 GeneTech Pharm Description and Business Overview
6.3.3 GeneTech Pharm Voriconazole Sales, Revenue and Gross Margin (2019-2024)
6.3.4 GeneTech Pharm Voriconazole Product Portfolio
6.3.5 GeneTech Pharm Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Voriconazole Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis Voriconazole Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Mylan
6.5.1 Mylan Corporation Information
6.5.2 Mylan Description and Business Overview
6.5.3 Mylan Voriconazole Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Mylan Voriconazole Product Portfolio
6.5.5 Mylan Recent Developments/Updates
6.6 Squibb
6.6.1 Squibb Corporation Information
6.6.2 Squibb Description and Business Overview
6.6.3 Squibb Voriconazole Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Squibb Voriconazole Product Portfolio
6.6.5 Squibb Recent Developments/Updates
6.7 Sandoz
6.6.1 Sandoz Corporation Information
6.6.2 Sandoz Description and Business Overview
6.6.3 Sandoz Voriconazole Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sandoz Voriconazole Product Portfolio
6.7.5 Sandoz Recent Developments/Updates
6.8 Daiichi Sankyo
6.8.1 Daiichi Sankyo Corporation Information
6.8.2 Daiichi Sankyo Description and Business Overview
6.8.3 Daiichi Sankyo Voriconazole Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Daiichi Sankyo Voriconazole Product Portfolio
6.8.5 Daiichi Sankyo Recent Developments/Updates
6.9 GSK
6.9.1 GSK Corporation Information
6.9.2 GSK Description and Business Overview
6.9.3 GSK Voriconazole Sales, Revenue and Gross Margin (2019-2024)
6.9.4 GSK Voriconazole Product Portfolio
6.9.5 GSK Recent Developments/Updates
6.10 Cilag AG
6.10.1 Cilag AG Corporation Information
6.10.2 Cilag AG Description and Business Overview
6.10.3 Cilag AG Voriconazole Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Cilag AG Voriconazole Product Portfolio
6.10.5 Cilag AG Recent Developments/Updates
6.11 Macherey-Nagel GmbH
6.11.1 Macherey-Nagel GmbH Corporation Information
6.11.2 Macherey-Nagel GmbH Voriconazole Description and Business Overview
6.11.3 Macherey-Nagel GmbH Voriconazole Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Macherey-Nagel GmbH Voriconazole Product Portfolio
6.11.5 Macherey-Nagel GmbH Recent Developments/Updates
6.12 Abbott
6.12.1 Abbott Corporation Information
6.12.2 Abbott Voriconazole Description and Business Overview
6.12.3 Abbott Voriconazole Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Abbott Voriconazole Product Portfolio
6.12.5 Abbott Recent Developments/Updates
6.13 Takeda
6.13.1 Takeda Corporation Information
6.13.2 Takeda Voriconazole Description and Business Overview
6.13.3 Takeda Voriconazole Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Takeda Voriconazole Product Portfolio
6.13.5 Takeda Recent Developments/Updates
6.14 Sichuan Beauty Sport Huakang Pharmaceutical
6.14.1 Sichuan Beauty Sport Huakang Pharmaceutical Corporation Information
6.14.2 Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Description and Business Overview
6.14.3 Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Product Portfolio
6.14.5 Sichuan Beauty Sport Huakang Pharmaceutical Recent Developments/Updates
6.15 Jincheng HEALTH Pharmaceutical
6.15.1 Jincheng HEALTH Pharmaceutical Corporation Information
6.15.2 Jincheng HEALTH Pharmaceutical Voriconazole Description and Business Overview
6.15.3 Jincheng HEALTH Pharmaceutical Voriconazole Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Jincheng HEALTH Pharmaceutical Voriconazole Product Portfolio
6.15.5 Jincheng HEALTH Pharmaceutical Recent Developments/Updates
6.16 Ebang Pharmaceutical
6.16.1 Ebang Pharmaceutical Corporation Information
6.16.2 Ebang Pharmaceutical Voriconazole Description and Business Overview
6.16.3 Ebang Pharmaceutical Voriconazole Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Ebang Pharmaceutical Voriconazole Product Portfolio
6.16.5 Ebang Pharmaceutical Recent Developments/Updates
6.17 Aditya Pharma
6.17.1 Aditya Pharma Corporation Information
6.17.2 Aditya Pharma Voriconazole Description and Business Overview
6.17.3 Aditya Pharma Voriconazole Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Aditya Pharma Voriconazole Product Portfolio
6.17.5 Aditya Pharma Recent Developments/Updates
6.18 Taj Pharmaceuticals
6.18.1 Taj Pharmaceuticals Corporation Information
6.18.2 Taj Pharmaceuticals Voriconazole Description and Business Overview
6.18.3 Taj Pharmaceuticals Voriconazole Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Taj Pharmaceuticals Voriconazole Product Portfolio
6.18.5 Taj Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Voriconazole Industry Chain Analysis
7.2 Voriconazole Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Voriconazole Production Mode & Process
7.4 Voriconazole Sales and Marketing
7.4.1 Voriconazole Sales Channels
7.4.2 Voriconazole Distributors
7.5 Voriconazole Customers
8 Voriconazole Market Dynamics
8.1 Voriconazole Industry Trends
8.2 Voriconazole Market Drivers
8.3 Voriconazole Market Challenges
8.4 Voriconazole Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
